1. Home
  2. FOSL vs ARCT Comparison

FOSL vs ARCT Comparison

Compare FOSL & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$4.49

Market Cap

208.1M

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$9.12

Market Cap

189.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
ARCT
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.1M
189.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FOSL
ARCT
Price
$4.49
$9.12
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$7.00
$24.11
AVG Volume (30 Days)
658.8K
317.6K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
$12.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.21
$5.85
52 Week High
$5.75
$24.14

Technical Indicators

Market Signals
Indicator
FOSL
ARCT
Relative Strength Index (RSI) 41.66 62.55
Support Level $3.80 $6.08
Resistance Level $5.01 $15.83
Average True Range (ATR) 0.24 0.48
MACD -0.11 -0.03
Stochastic Oscillator 12.46 94.33

Price Performance

Historical Comparison
FOSL
ARCT

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: